BARCLAYS PLC - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 121 filers reported holding CTI BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$2,256
-50.5%
536,999
-29.2%
0.00%
-50.0%
Q4 2022$4,557
-99.9%
758,361
+11.8%
0.00%
-50.0%
Q3 2022$3,950,000
+14007.1%
678,613
+14450.0%
0.00%
Q2 2022$28,0004,664
+29050.0%
0.00%
Q1 2022$0
-100.0%
16
-98.4%
0.00%
Q4 2021$2,000
-97.4%
1,032
-96.0%
0.00%
Q3 2021$77,000
+450.0%
26,108
+365.8%
0.00%
Q2 2021$14,000
-92.6%
5,605
-91.4%
0.00%
Q1 2021$190,000
+9400.0%
64,954
+12463.6%
0.00%
Q4 2020$2,000
+100.0%
5170.0%0.00%
Q3 2020$1,000
-50.0%
517
-63.0%
0.00%
Q2 2020$2,0001,397
+170.2%
0.00%
Q1 2020$0
-100.0%
5170.0%0.00%
Q4 2019$1,0005170.0%0.00%
Q3 2019$0517
-48.7%
0.00%
Q2 2019$0
-100.0%
1,007
-93.3%
0.00%
Q1 2019$15,00014,955
+2792.6%
0.00%
Q4 2018$0
-100.0%
517
-97.8%
0.00%
Q3 2018$51,000
-73.6%
23,764
-38.5%
0.00%
Q2 2018$193,000
+0.5%
38,670
-21.6%
0.00%
Q1 2018$192,000
+19100.0%
49,324
+9349.0%
0.00%
Q4 2017$1,000
-50.0%
5220.0%0.00%
Q3 2017$2,0000.0%5220.0%0.00%
Q2 2017$2,0000.0%5220.0%0.00%
Q1 2017$2,0005220.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 6,535,674$27,449,8319.21%
Bleichroeder LP 3,893,730$16,353,6663.49%
AIGH Capital Management LLC 2,100,000$8,820,0003.25%
Ally Bridge Group (NY) LLC 550,000$2,310,0003.03%
Ghost Tree Capital, LLC 2,000,000$8,400,0002.48%
Bain Capital Life Sciences Investors, LLC 4,702,996$19,7532.47%
Altium Capital Management LP 850,000$3,570,0001.98%
Parkman Healthcare Partners LLC 1,753,630$7,365,2461.60%
BVF INC/IL 8,813,021$37,014,6881.35%
Sio Capital Management, LLC 526,239$2,210,2041.09%
View complete list of CTI BIOPHARMA CORP shareholders